Horseminth 152.3 mg/g Pâte orale
Horseminth 152.3 mg/g Pâte orale
Authorised
- Pyrantel embonate
Product identification
Medicine name:
Horseminth 152.3 mg/g Pâte orale
Active substance:
- Pyrantel embonate
Target species:
-
Horse
-
Horse (pony)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pyrantel embonate439.00milligram(s)1.00Dose
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
- Horse
-
Meat and offal, milkno withdrawal period0 days
-
- Horse (pony)
-
Meat and offal, milkno withdrawal period0 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AF02
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Horseminth 26 g Pre-filled syringe Oral paste
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Le Ministère De La Santé Division De La Pharmacie Et Des Médicaments
Authorisation number:
- V 087/87/06/0096
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 28/11/2022
How useful was this page?: